Inflammatory Bowel Disease: Clinical Advances and Therapeutic Prospects
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 25 October 2024 | Viewed by 66
Special Issue Editor
2. Internal Medicine Department, Hospital Comarcal "Santa Ana", 18600 Motril, Spain
Interests: endoscopy; biliary tract diseases; pancreatic diseases; liver cirrhosis; inflammatory bowel disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, casts a long shadow over the lives of millions worldwide. The relentless cycle of inflammation, pain, and uncertainty can be immensely debilitating, demanding not only exceptional medical care but also unwavering resilience from patients. Yet, amidst the challenges, a beacon of hope shines brightly: unprecedented scientific advancements are illuminating the path towards better diagnosis, more effective treatments, and improved quality of life for individuals living with IBD.
Having cared for IBD patients firsthand, I understand the profound impact this disease has on their lives. The relentless symptoms and uncertainty can be truly devastating. This Special Issue offers a unique opportunity to showcase research addressing not only the biological aspects of IBD but also the holistic needs of patients, ultimately improving their quality of life and well-being. We invite you to contribute your groundbreaking work, illuminating diverse aspects of the disease journey, from the intricate dance of genetic and environmental factors to the development of personalized therapeutic strategies.
Dr. Antonio M. Caballero-Mateos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- Crohn's disease
- ulcerative colitis
- risk factors
- therapeutic strategies
